BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23704073)

  • 1. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
    Li MH; Hla T; Ferrer F
    Pediatr Blood Cancer; 2013 Sep; 60(9):1418-23. PubMed ID: 23704073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
    Don AS; Martinez-Lamenca C; Webb WR; Proia RL; Roberts E; Rosen H
    J Biol Chem; 2007 May; 282(21):15833-42. PubMed ID: 17400555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
    Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
    Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
    J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipid modulation of angiogenic factor expression in neuroblastoma.
    Li MH; Hla T; Ferrer F
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1325-32. PubMed ID: 21576349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
    Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro.
    Marvaso G; Barone A; Amodio N; Raimondi L; Agosti V; Altomare E; Scotti V; Lombardi A; Bianco R; Bianco C; Caraglia M; Tassone P; Tagliaferri P
    Cancer Biol Ther; 2014 Jun; 15(6):797-805. PubMed ID: 24657936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.
    Zemann B; Kinzel B; Müller M; Reuschel R; Mechtcheriakova D; Urtz N; Bornancin F; Baumruker T; Billich A
    Blood; 2006 Feb; 107(4):1454-8. PubMed ID: 16223773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
    Nagaoka Y; Otsuki K; Fujita T; Uesato S
    Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
    Omar HA; Chou CC; Berman-Booty LD; Ma Y; Hung JH; Wang D; Kogure T; Patel T; Terracciano L; Muthusamy N; Byrd JC; Kulp SK; Chen CS
    Hepatology; 2011 Jun; 53(6):1943-58. PubMed ID: 21391227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
    Paugh SW; Payne SG; Barbour SE; Milstien S; Spiegel S
    FEBS Lett; 2003 Nov; 554(1-2):189-93. PubMed ID: 14596938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic, biochemical, and transcriptional responses of Saccharomyces cerevisiae to the novel immunomodulator FTY720 largely mimic those of the natural sphingolipid phytosphingosine.
    Welsch CA; Roth LW; Goetschy JF; Movva NR
    J Biol Chem; 2004 Aug; 279(35):36720-31. PubMed ID: 15190065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
    Alinari L; Mahoney E; Patton J; Zhang X; Huynh L; Earl CT; Mani R; Mao Y; Yu B; Quinion C; Towns WH; Chen CS; Goldenberg DM; Blum KA; Byrd JC; Muthusamy N; Praetorius-Ibba M; Baiocchi RA
    Blood; 2011 Dec; 118(26):6893-903. PubMed ID: 22042694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
    Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L
    J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
    Spijkers LJ; Alewijnse AE; Peters SL
    Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
    Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
    BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.
    Sanchez T; Estrada-Hernandez T; Paik JH; Wu MT; Venkataraman K; Brinkmann V; Claffey K; Hla T
    J Biol Chem; 2003 Nov; 278(47):47281-90. PubMed ID: 12954648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
    Hait NC; Wise LE; Allegood JC; O'Brien M; Avni D; Reeves TM; Knapp PE; Lu J; Luo C; Miles MF; Milstien S; Lichtman AH; Spiegel S
    Nat Neurosci; 2014 Jul; 17(7):971-80. PubMed ID: 24859201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
    Chen L; Luo LF; Lu J; Li L; Liu YF; Wang J; Liu H; Song H; Jiang H; Chen SJ; Luo C; Li KK
    PLoS One; 2014; 9(7):e103033. PubMed ID: 25050888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.